HER2, Mesothelin, PSCA, MUC1, Lewis-Y, GPC3, AXL, EGFR, Claudin18.2/6, ROR1, GD1, B7-H3 targeting CAR-TILs
/ Zhaotai InVivo Biomedicine
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 25, 2024
Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=40 | Recruiting | Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Trial primary completion date: Dec 2025 ➔ Dec 2029
Metastases • Trial primary completion date • Brain Cancer • Breast Cancer • Colorectal Cancer • Gastrointestinal Cancer • Hepatology • Liver Cancer • Lung Cancer • Oncology • Solid Tumor
February 28, 2023
Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=40 | Recruiting | Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Trial primary completion date: Dec 2023 ➔ Dec 2025
Metastases • Trial primary completion date • Brain Cancer • Breast Cancer • Colorectal Cancer • Gastrointestinal Cancer • Hepatology • Liver Cancer • Lung Cancer • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1